PL2361303T3 - Wyodrębniona multipotencjalna mezenchymalna komórka macierzysta z kłębuszków nerkowych człowieka dorosłego (hgl-msc), sposób jej otrzymywania i jej zastosowania w medycynie regeneracyjnej nerki - Google Patents

Wyodrębniona multipotencjalna mezenchymalna komórka macierzysta z kłębuszków nerkowych człowieka dorosłego (hgl-msc), sposób jej otrzymywania i jej zastosowania w medycynie regeneracyjnej nerki

Info

Publication number
PL2361303T3
PL2361303T3 PL09744160.4T PL09744160T PL2361303T3 PL 2361303 T3 PL2361303 T3 PL 2361303T3 PL 09744160 T PL09744160 T PL 09744160T PL 2361303 T3 PL2361303 T3 PL 2361303T3
Authority
PL
Poland
Prior art keywords
hgl
msc
kidney
preparing
stem cell
Prior art date
Application number
PL09744160.4T
Other languages
English (en)
Polish (pl)
Inventor
Giovanni Camussi
Stefania Bruno
Benedetta Bussolati
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL2361303T3 publication Critical patent/PL2361303T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0687—Renal stem cells; Renal progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL09744160.4T 2008-11-04 2009-11-02 Wyodrębniona multipotencjalna mezenchymalna komórka macierzysta z kłębuszków nerkowych człowieka dorosłego (hgl-msc), sposób jej otrzymywania i jej zastosowania w medycynie regeneracyjnej nerki PL2361303T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08425708A EP2186883A1 (en) 2008-11-04 2008-11-04 An isolated multipotent mesenchymal stem cell from human adult glomeruli (hGL-MSC), a method of preparing thereof and uses thereof in the regenerative medicine of the kidney

Publications (1)

Publication Number Publication Date
PL2361303T3 true PL2361303T3 (pl) 2016-10-31

Family

ID=40260686

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09744160.4T PL2361303T3 (pl) 2008-11-04 2009-11-02 Wyodrębniona multipotencjalna mezenchymalna komórka macierzysta z kłębuszków nerkowych człowieka dorosłego (hgl-msc), sposób jej otrzymywania i jej zastosowania w medycynie regeneracyjnej nerki

Country Status (7)

Country Link
US (1) US9499796B2 (https=)
EP (2) EP2186883A1 (https=)
JP (1) JP5795737B2 (https=)
CN (1) CN102292434B (https=)
ES (1) ES2580172T3 (https=)
PL (1) PL2361303T3 (https=)
WO (1) WO2010052192A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2363136A1 (en) 2010-03-02 2011-09-07 Fresenius Medical Care Deutschland GmbH Microvesicles (MVs) derived from adult stem cells for use in the therapeutic treatment of a tumor disease
TWI762890B (zh) 2010-05-12 2022-05-01 開曼群島商英瑞金公司 生物活性腎細胞
WO2012030968A1 (en) * 2010-08-31 2012-03-08 Renovocyte, LLC Systemic, allogenic stem cell therapies for treatment of diseases in animals
CN103261407B (zh) * 2010-12-22 2016-03-02 杜兰教育基金委员会 用于识别和培养具有高度增殖潜能的多能间充质干细胞的方法
AU2012279995C1 (en) 2011-07-06 2019-10-24 Cell Therapy Limited Progenitor cells of mesodermal lineage
EP2760995B1 (en) * 2011-09-30 2019-08-07 The University Of Miami Renal stem cells isolated from kidney
RU2702721C2 (ru) 2012-10-24 2019-10-09 инРиджен Популяции клеток почек и их применение
WO2014113704A2 (en) * 2013-01-18 2014-07-24 Escape Therapeutics, Inc. Enhanced differentiation of mesenchymal stem cells
CN104977414B (zh) * 2014-04-09 2016-09-28 上海交通大学医学院 鉴定骨髓中是否存在保护白血病干细胞微环境的试剂盒及其应用
CN106715683A (zh) * 2014-08-21 2017-05-24 味之素株式会社 间充质干细胞用培养基
TWI689589B (zh) * 2016-08-31 2020-04-01 宣捷細胞生物製藥股份有限公司 區別間質幹細胞的方法及測定間質幹細胞的純度的方法
CN106265745A (zh) * 2016-09-30 2017-01-04 广州赛莱拉干细胞科技股份有限公司 一种干细胞制剂及其在制备治疗慢性肾炎的药物中的应用
JP7072777B2 (ja) * 2018-07-03 2022-05-23 株式会社生命科学インスティテュート 慢性腎障害治療のための多能性幹細胞
EP4146787A4 (en) 2020-05-08 2024-06-26 Gallant Pet, Inc. Uterine-derived regenerative cell compositions and uses thereof
CN117871216B (zh) * 2024-03-12 2024-06-04 中日友好医院(中日友好临床医学研究所) 一种石蜡标本中肾小球裂隙膜的三维可视化方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4085410B2 (ja) * 2003-03-14 2008-05-14 株式会社 バイオリンクインク 腎臓幹細胞／前駆細胞、腎臓幹細胞／前駆細胞の分離方法、及び腎疾患の治療方法
ITFI20060099A1 (it) * 2006-04-28 2007-10-29 Azienda Ospedaliera Careggi Popolazione di cellule staminali renali, sua identificazione ed uso per finalita' terapeutiche
CN101595212B (zh) * 2006-10-12 2014-04-30 伊西康公司 肾源细胞及在组织修复和再生中的使用方法

Also Published As

Publication number Publication date
JP2012507304A (ja) 2012-03-29
US9499796B2 (en) 2016-11-22
CN102292434B (zh) 2014-03-12
WO2010052192A1 (en) 2010-05-14
US20110256111A1 (en) 2011-10-20
JP5795737B2 (ja) 2015-10-14
EP2361303B8 (en) 2016-08-10
CN102292434A (zh) 2011-12-21
EP2361303B1 (en) 2016-04-06
EP2361303A1 (en) 2011-08-31
EP2186883A1 (en) 2010-05-19
ES2580172T3 (es) 2016-08-19

Similar Documents

Publication Publication Date Title
PL2361303T3 (pl) Wyodrębniona multipotencjalna mezenchymalna komórka macierzysta z kłębuszków nerkowych człowieka dorosłego (hgl-msc), sposób jej otrzymywania i jej zastosowania w medycynie regeneracyjnej nerki
IL283597A (en) A pluripotent stem cell growth medium containing human serum and without a nutrient layer
WO2009007852A3 (en) Multipotent/pluripotent cells and methods
WO2010111409A3 (en) Pluripotent stem cells
GB0907978D0 (en) Multipotent adult stem cell population
PL2495302T3 (pl) Urządzenie biologiczne do ekstrakcji krwiotwórczych komórek macierzystych i mezenchymalnych komórek macierzystych z krwi obwodowej
ZA201606403B (en) Pluripotent stem cell culture on micro-carriers
WO2009092005A3 (en) Methods of generating cardiomyocytes and cardiac progenitors and compositions
IL202401A0 (en) Methods for production and uses of multipotent cell populations, pluripotent cell populations, differentiated cell populations, and hiv -resistant cell populations
WO2011024172A3 (en) Liposomal compositions and uses of same
WO2009148620A3 (en) Anthraquinones and analogs from rhuem palmatum for treatment of estrogen receptor beta-mediated conditions
WO2010111659A8 (en) Tumor-initiating cells and methods for using same
WO2010014949A3 (en) Compositions comprising hepatocyte-like cells and uses thereof
AU2012248333A2 (en) Pluripotent stem cell-derived brown adipocytes, pluripotent stem cell-derived cell aggregate, method for producing same, and cell therapy and medical therapy therefor
WO2011100286A3 (en) Compositions and methods of generating a differentiated mesodermal cell
ZA201200167B (en) Methods of generating hybrid/chimeric cells, and uses thereof
WO2011032025A3 (en) Adipose-derived induced pluripotent stem cells
ZA201201011B (en) Process for preparing levosimendan and intermediates for use in the process
EP2294182A4 (en) CULTS OF MULTIPOTENT STEM CELLS
IL212638A (en) Stem cells derived from monocytes, a method for producing their own uses
PH12012500315A1 (en) Ursodeoxycholic acid-synthetic hydrotalcite-eudragit hybrid, pharmaceutical composition containing the same and method for preparing the same
EP2380973A4 (en) PREPARATION BASED ON REPROGRAMMABLE CELL SIGNALING STEM CELLS, METHOD OF MAKING THE PREPARATION AND USE THEREOF
GB2458429B (en) Novel mesenchymal progenitor cells derived from human blastocyst-derived stem cells
WO2012058291A3 (en) Methods and compositions for differentiating embryonic stem cells
WO2010065776A3 (en) Identification of neuroprotective agents using pro-inflammatory human glial cells